RU 486: what physicians know, think and (might) do--a survey of California obstetrician/gynecologists.
The results of this informal survey indicate that a solid majority of California obstetricians and gynecologists are very interested in RU 486 and are following its story closely; that this majority is confident in the research already conducted on the drug, and feel that RU 486 should be made available at this time for both clinical practice and additional research; that many physicians already performing abortions would utilize RU 486 in their practices; and that a significant number of physicians not currently performing abortions would do so using RU 486, thus potentially increasing access to early abortion services in this country. However, strong support for RU 486 among American physicians has not yet had an appreciable impact on hastening the eventual availability of RU 486 in the United States.
Heilig
S L
SL
D000021:Abortifacient Agents, Steroidal; D001291:Attitude of Health Personnel; D002140:California; D005260:Female; D006176:Gynecology; D007722:Health Knowledge, Attitudes, Practice; D006801:Humans; D015735:Mifepristone; D009774:Obstetrics; D011247:Pregnancy; D018570:Risk Assessment
D000021:Abortifacient Agents, Steroidal; D015735:Mifepristone